Atlas Trials

Study of Fuquinitinib Combined With Capecitabine First-line Maintenance in the Treatment of Metastatic Colorectal Cancer

Clinical trial NCT06115733 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06115733
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Colorectal Carcinoma
Start date
2023-12-28
Primary completion
2026-12-15
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.